Ruijin Hospital

This early-phase study tests a new drug called CS01 in about 10 people with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors. The study is currently active but…

This study tests a drug called TMF (Amibufenamide) in 200 adults with chronic hepatitis B who have normal ALT levels. The goal is to see if TMF can lower the amount of hepatitis B virus in the blood and possibly clear a key marker of infection (HBsAg). Participants are randomly a…

This study tests whether a blood test that measures CMV-specific immunity can help doctors decide how long to use the antiviral drug letermovir after a stem cell transplant. The goal is to prevent late-onset CMV infection, a common and serious complication. The trial involves 250…

This study tests a gentle, non-invasive brain stimulation technique called tTIS in 100 people with early to mid-stage Parkinson's disease. The goal is to see if it can improve movement problems like tremors and stiffness when medication is not working. Each participant will try t…

This study looks at 792 people who need heart valve surgery and also have blocked heart arteries. It compares two methods—standard angiography and a newer computer-based method called Quantitative Flow Ratio (QFR)—to decide which arteries need a stent. The goal is to see if QFR g…

This study follows 500 heart bypass patients for 10 years to see if taking two blood thinners (ticagrelor plus aspirin) for one year after surgery reduces the risk of heart attacks, strokes, or death compared to taking just one. Participants will be contacted by phone to report t…

This study reviews medical records of 102 adults with B-cell acute lymphoblastic leukemia (B-ALL) who received the drug inotuzumab ozogamicin. The goal is to measure how many patients achieved complete remission and cleared minimal residual disease. No new treatments are given; t…